Cellular and Molecular Life Sciences

, Volume 68, Issue 24, pp 3995–4008

Specification of neuronal and glial subtypes from human pluripotent stem cells

Authors

  • Huisheng Liu
    • Waisman CenterUniversity of Wisconsin
    • Waisman CenterUniversity of Wisconsin
    • Department of Neuroscience and Department of NeurologySchool of Medicine and Public Health, University of Wisconsin
Review

DOI: 10.1007/s00018-011-0770-y

Cite this article as:
Liu, H. & Zhang, S. Cell. Mol. Life Sci. (2011) 68: 3995. doi:10.1007/s00018-011-0770-y

Abstract

Human pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), provide a dynamic tool for revealing early embryonic development, modeling pathological processes, and developing therapeutics through drug discovery and potential cell replacement. The first step toward the utilities of human PSCs is directed differentiation to functionally specialized cell/tissue types. Following developmental principles, human ESCs, and lately iPSCs, have been effectively differentiated to region- and/or transmitter-specific neuronal and glial types, including cerebral glutamatergic, striatal γ-aminobutyric acid (GABA)-ergic, forebrain cholinergic, midbrain dopaminergic, and spinal motor neurons, as well as astrocytes and oligodendrocytes. These studies also reveal unique aspects of human cell biology, including intrinsically programmed developmental course, differential uses of transcription factors for neuroectoderm specification, and distinct responses to extracellular signals in regulating cell fate. Such information will be instrumental in translating biological findings to therapeutic development.

Keywords

Embryonic stem cellsInduced pluripotent stem cellsNeural stem cellsPatterningTranscriptional regulationTransplantationDrug screening

Copyright information

© Springer Basel AG 2011